Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 611-930-7 | CAS number: 60045-26-3
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 01November 2013 to 29 November 2013
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study carried out to guideline requiremnets and in compliance with GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 014
- Report date:
- 2014
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: JMAFF 12 Nousan No 8147, 2000
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- certificate of Compliance with GLP issued by UK GLP Monitoring Authority included in report
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- 3-phenylpropyl benzoate
- EC Number:
- 611-930-7
- Cas Number:
- 60045-26-3
- Molecular formula:
- C16H16O2
- IUPAC Name:
- 3-phenylpropyl benzoate
- Reference substance name:
- Kalama® K-Flex® 613
- IUPAC Name:
- Kalama® K-Flex® 613
- Test material form:
- other: clear colourless liquid
- Details on test material:
- - Name of test material (as cited in study report): 3-Phylpropyl benzoate
- Physical state: clear, colourless liquid
- Analytical purity: 99.1%
- Lot/batch No.: EH101912A
- Expiration date of the lot/batch: 19 October 2014
- Storage condition of test material: Room temperature under Nitrogen
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- other: Sprague Dawley Crl:CD (SD)
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: UK
- Age at study initiation: 8 - 12 weeks
- Weight at study initiation: 226 - 240g
- Fasting period before study: overnight
- Housing: Group housing 3 per cage
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum):ad libitum
- Acclimation period: at least 6 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 -23 deg C
- Humidity (%): 40 - 70%
- Air changes (per hr):
- Photoperiod (hrs dark / hrs light): 12 hrs dark / 12 hrs light
IN-LIFE DATES: From: 07 November To: 29 November
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 200 mg/ml
- Amount of vehicle (if gavage): 10mL/kg bodyweight
- Justification for choice of vehicle: none stated
- Lot/batch no. (if required):
- Purity:
MAXIMUM DOSE VOLUME APPLIED:
DOSAGE PREPARATION (if unusual):
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: - Doses:
- 2000 mg/animal
- No. of animals per sex per dose:
- 6 females
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: frequent observations on day of dosing and twice per day thereafter
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight,other: macroscopic pathology of vranial, thoracic and abdominal cavities
Results and discussion
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- no deaths during study
- Clinical signs:
- Loose faeces in two females dosed at 2000 mg/kg. first noted 30 min after dosing and then not observed from end of Day 2 onwards
- Body weight:
- Bodyweight loss noted in one rat, all other rats achieved satisfactory bodyweight gain
- Gross pathology:
- NO abnormalities noted
- Other findings:
- None
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Acute median lethal dose (LD50) to rats of 3-Phenylpropyl benzoate was >2000 mg/kg bodyweight
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
